LeAnne M. Zumwalt's most recent trade in Akebia Therapeutics Inc. was a trade of 53,600 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 53,600 | 53,600 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 35,700 | 109,400 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,000 | 73,700 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 43,700 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 13,700 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 80,200 | 80,200 | - | - | Stock Option (Right to buy) | |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.42 per share. | 18 Sep 2020 | 26,459 | 51,049 (0%) | 0% | 75.4 | 1,995,538 | Common Stock |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2020 | 26,459 | 26,459 | - | - | Stock Appreciation Rights | |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.14 per share. | 18 Sep 2020 | 24,190 | 26,859 (0%) | 0% | 90.1 | 2,180,487 | Common Stock |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.48 per share. | 18 Sep 2020 | 10,464 | 37,323 (0%) | 0% | 65.5 | 685,183 | Common Stock |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2020 | 10,456 | 10,456 | - | - | Stock Appreciation Rights | |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.14 per share. | 18 Sep 2020 | 8,961 | 28,362 (0%) | 0% | 90.1 | 807,745 | Common Stock |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Sale of securities on an exchange or to another person at price $ 87.73 per share. | 18 Sep 2020 | 2,435 | 25,927 (0%) | 0% | 87.7 | 213,618 | Common Stock |
| DaVita | LeAnne M. Zumwalt | Group VP, Government Affairs | Sale of securities on an exchange or to another person at price $ 88.57 per share. | 18 Sep 2020 | 1,337 | 24,590 (0%) | 0% | 88.6 | 118,412 | Common Stock |